DICE Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2022 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
DICE Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2022 to Q2 2023.
  • DICE Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2023 was $12.3M, a 11% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $12.3M -$1.53M -11% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $12.7M -$1.62M -11.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $13.1M Dec 31, 2022 10-Q 2023-08-08
Q3 2022 $13.5M Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $13.8M Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $14.3M Mar 31, 2022 10-Q 2022-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.